Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Bioatla, Inc. (BCAB)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 46,110,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   BioAtla is a biopharmaceutical company engaged in developing specific and selective antibody-based therapeutics for the treatment of various cancers. Co.'s lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and other tumor types. Co. also develops BA3021, a CAB ADC for NSCLC and Melanoma; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 81,495 83,495 252,735
Total Buy Value $0 $172,540 $177,620 $814,041
Total People Bought 0 4 4 4
Total Buy Transactions 0 4 5 15
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 207
  Page 5 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Short Jay M Phd Chief Executive Officer   •       •       •   2022-07-31 4 D $3.40 $9,819 D/D (2,888) 1,370,206     -
   Vasquez Christian See Remarks   •       –      –    2022-07-31 4 D $3.40 $660 D/D (194) 74,137     -
   Sievers Eric Chief Medical Officer   •       –      –    2022-07-31 4 D $3.40 $1,884 D/D (554) 86,727     -
   Waldron Richard A Chief Financial Officer   •       –      –    2022-07-31 4 D $3.40 $3,298 D/D (970) 126,624     -
   Smith Scott Andrew President   •       •      –    2022-07-31 4 D $3.40 $6,089 D/D (1,791) 329,835     -
   Short Jay M Phd Chief Executive Officer   •       •       •   2022-06-30 4 D $2.85 $8,231 D/D (2,888) 1,373,094     -
   Waldron Richard A Chief Financial Officer   •       –      –    2022-06-30 4 D $2.85 $2,765 D/D (970) 127,594     -
   Vasquez Christian See Remarks   •       –      –    2022-06-30 4 D $2.85 $553 D/D (194) 74,331     -
   Smith Scott Andrew President   •       •      –    2022-06-30 4 D $2.85 $5,104 D/D (1,791) 331,626     -
   Sievers Eric Chief Medical Officer   •       –      –    2022-06-30 4 D $2.85 $1,582 D/D (555) 87,281     -
   Short Jay M Phd Chief Executive Officer   •       •       •   2022-06-22 4 AB $2.91 $117,296 D/D 40,308 1,375,982     -
   Short Jay M Phd Chief Executive Officer   •       •       •   2022-06-21 4 AB $2.79 $81,040 D/D 29,082 1,335,674     -
   Smith Scott Andrew President   •       •      –    2022-05-31 4 D $2.41 $4,316 D/D (1,791) 333,417     -
   Short Jay M Phd Chief Executive Officer   •       •       •   2022-05-31 4 D $2.41 $6,960 D/D (2,888) 1,306,592     -
   Vasquez Christian See Remarks   •       –      –    2022-05-31 4 D $2.41 $468 D/D (194) 24,525     -
   Waldron Richard A Chief Financial Officer   •       –      –    2022-05-31 4 D $2.41 $2,338 D/D (970) 128,564     -
   Sievers Eric Chief Medical Officer   •       –      –    2022-05-31 4 D $2.41 $1,335 D/D (554) 87,836     -
   Smith Scott Andrew President   •       •      –    2022-03-31 4 D $5.00 $8,955 D/D (1,791) 336,999     -
   Vasquez Christian See Remarks   •       –      –    2022-03-31 4 D $5.00 $945 D/D (189) 24,908     -
   Waldron Richard A Chief Financial Officer   •       –      –    2022-03-31 4 D $5.00 $4,850 D/D (970) 130,504     -
   Short Jay M Phd Chief Executive Officer   •       •       •   2022-03-31 4 D $5.00 $14,440 D/D (2,888) 1,306,990     -
   Sievers Eric Chief Medical Officer   •       –      –    2022-03-31 4 D $5.00 $2,770 D/D (554) 88,945     -
   Sievers Eric Chief Medical Officer   •       –      –    2022-02-28 4 D $6.48 $3,596 D/D (555) 89,499     -
   Smith Scott Andrew President   •       •      –    2022-02-28 4 D $6.48 $11,606 D/D (1,791) 338,790     -
   Waldron Richard A Chief Financial Officer   •       –      –    2022-02-28 4 D $6.48 $6,286 D/D (970) 131,474     -
  207 Records found
  1  2  3  4  5  6  7  8  9   
  Page 5 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us